SaverOne 2014 Ltd. (SVRE) is a Petah Tikva, Israel-based transportation-safety technology company whose Driver Distraction Prevention System detects and selectively blocks phone use by drivers, sold mainly to commercial fleets in Israel, Europe, and North America. It has also pushed into RF sensing and defense applications. In Friday's session, which is open, the stock traded at $1.22, up $0.10 or 8.93%, from the prior completed close of $1.12 on Nov. 19. The direction is clearly higher, but the move came with no verified company news or fundamental catalyst identified — it is a continuation of the speculative rebound that began two sessions earlier.
No verified news or fundamental catalyst found to explain today's advance. The company published nothing material between Thursday's close and Friday's open, no analyst initiated or changed coverage, and no filing disclosed a new contract or financing. The most plausible assessment is technical and behavioral: the stock collapsed about 89% between mid-August and Tuesday's 52-week low of $0.38, and that kind of selling exhaustion in a low-float name makes it unusually easy for a modest inflow of buy orders to gap the price higher. Wednesday's range alone ran from $0.68 to $1.15, an intraday spread wider than the stock's entire 60-day trading range. Today's advance, by comparison, is modest: the stock is still below its 50-day moving average and about 94% below its 52-week high of $19.92, a pattern consistent with a violent oversold bounce rather than a fundamental re-rating.
The company has produced a steady stream of routine updates. On Oct. 26 it unveiled a software-only edition of its driver-safety platform aimed at fleets, insurers, and private vehicles, with integrations with telematics providers including Geotab and Ituran. In September it expanded its collaboration with CX (Cemex Germany) to heavy trucks and was granted a U.S. patent covering automated sensor-fusion calibration. More recently, it signed a first Canadian distribution agreement with MRF Geosystems covering Alberta with a first-six-months target of 1,000 units, and it has pursued a defense pivot through a 33.3% stake in Italy's Gryphen Aircraft and its tie-up with VisionWave Holdings (VWAV). Each item adds to a recovery narrative, but collectively they represent a few thousand units of potential volume and patent protection — marginal relative to a market capitalization of roughly $3 million that nearly tripled in three sessions.
Volume is the tell. Wednesday's 60-million-share session compared with a 50-day average near 3.35 million, and Thursday followed with roughly 10.8 million shares — still more than three times normal. Early Friday turnover was a small fraction of that pace, suggesting thinner participation behind today's gain. The move diverged from the broader tape: on Nov. 18, when the stock doubled, the S&P 500 slipped about 0.23%, and there was no comparable strength in automotive-technology or ADAS peers. Technically, the shares have reclaimed the $1 level and cleared the Nov. 19 range high, but they remain below the 50-day moving average near $1.37 and far below longer-term trend levels, so the structure still reads as a counter-trend rebound inside a steep multi-month downtrend.
The score runs from 0 to 100, where 0 means no meaningful news and a normal move for the stock, and 100 means transformative news and an extreme, rare price move. This event scores 12 out of 100. Verified news was essentially absent: no release, filing, or analyst action accompanied the advance, and the recent product and distribution updates are too small relative to the company's size to qualify as material catalysts. The price move was equally unremarkable by this stock's own standards — today's 8.93% gain is only about 0.9 times its typical absolute daily move of roughly 10%, and 20 of the last 60 sessions produced swings as large or larger. Both components are weak, which produces a low score.
Attention turns to the company's next financial report, with interim and annual results expected in the first quarter of 2027, and to whether management discloses the commercial value of its recent distribution and fleet agreements. Investors will also watch for any filing that could explain the past week's trading, including equity or shelf registrations, given a long history of dilution and share consolidations. Surveillance items include the $1 threshold — a sustained slide back below it would revive minimum-bid listing concerns — and the durability of the software-only product rollout. There is no meaningful sell-side coverage or consensus estimate, so news flow, cash burn, and order announcements remain the primary swing factors. Risks are substantial: a micro-cap with minimal revenue, continuing losses, and a float that amplifies both directions.
Tickeron's Trending AI Robots page showcases a curated selection drawn from hundreds of AI trading bots covering thousands of tickers. Only the strongest performers under current market conditions make the list, and the bots vary widely by strategy, timeframe, performance metrics, and the symbols they trade. It is a practical starting point for investors comparing systematic approaches. Explore the page to see which AI strategies are leading right now.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The RSI Oscillator for SVRE moved out of oversold territory on November 18, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 53 similar instances when the indicator left oversold territory. In 47 of the 53 cases the stock moved higher. This puts the odds of a move higher at 89%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 52 of 60 cases where SVRE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.
The Momentum Indicator moved above the 0 level on November 18, 2026. You may want to consider a long position or call options on SVRE as a result. In 56 of 68 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for SVRE just turned positive on November 09, 2026. Looking at past instances where SVRE's MACD turned positive, the stock continued to rise in 35 of 42 cases over the following month. The odds of a continued upward trend are 83%.
Following a +173.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where SVRE advanced for three days, in 129 of 151 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SVRE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
SVRE broke above its upper Bollinger Band on November 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for SVRE entered a downward trend on November 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.063) is normal, around the industry mean (1.448). P/E Ratio (0.000) is within average values for comparable stocks, (5.350). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.470). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (5.848) is also within normal values, averaging (32.028).
The Tickeron Price Growth Rating for this company is 96 (best 1 - 100 worst), indicating slightly worse than average price growth. SVRE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SVRE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ElectronicEquipmentInstruments